Codman Neuro prepares to widen its Asia Pacific footprint with regulatory approvals in China, South Korea and Taiwan for its Revive SE thrombectomy system.
Massachusetts-based Codman Neuro is preparing to take Asia Pacific by storm with new regulatory wins in China, South Korea and Taiwan for the company's Revive SE thrombectomy device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xwWU9V
Cap comentari:
Publica un comentari a l'entrada